APOA1 and cardiovascular disorder: Specifically, apoAI and derivatives of apoAI (including the mutant form apoAIMilano bearing R173C, which was inspired by the naturally occurring genetic variant that afforded protection against cardiovascular disease) have received intense scrutiny over the last two decades in efforts to improve cardiovascular outcomes in human trials [28,29,30,31,32,33,34,35,36].